Source:http://linkedlifedata.com/resource/pubmed/id/15251989
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2004-10-22
|
pubmed:abstractText |
HLA matching between the donor and recipient improves the success of unrelated hematopoietic cell transplantation (HCT). Matched donors are available for only a minority of patients. Further information is needed to evaluate the limits of HLA mismatching. We examined the association of mortality with HLA-A, -B, -C, -DRB1, and -DQB1 mismatching in 948 patients who received a T-replete unrelated HCT for treatment of a marrow disorder. A single HLA allele or antigen mismatch was associated with increased mortality among patients with chronic myeloid leukemia (CML) within 2 years after diagnosis compared to patients with no HLA mismatch, but not among those with more advanced malignancy. In particular, a single HLA-C mismatch conferred increased risk of mortality compared to matches. There was a suggestion for increased mortality with multiple mismatches involving HLA-DQB1 compared to multiple mismatches not involving HLA-DQB1. Donors with a single HLA allele or antigen mismatch may be used for HCT when a fully matched donor is not available for patients with diseases that do not permit time for a lengthy search. Whenever possible, HLA-C mismatches should be avoided for patients with early stage CML, and HLA-DQB1 mismatches should be avoided for patients with multiple mismatches.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2976-80
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15251989-Alleles,
pubmed-meshheading:15251989-Female,
pubmed-meshheading:15251989-HLA Antigens,
pubmed-meshheading:15251989-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:15251989-Histocompatibility,
pubmed-meshheading:15251989-Histocompatibility Testing,
pubmed-meshheading:15251989-Humans,
pubmed-meshheading:15251989-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:15251989-Male,
pubmed-meshheading:15251989-Myeloablative Agonists,
pubmed-meshheading:15251989-Risk,
pubmed-meshheading:15251989-Survival Analysis,
pubmed-meshheading:15251989-Transplantation, Homologous,
pubmed-meshheading:15251989-Transplantation Immunology,
pubmed-meshheading:15251989-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
Limits of HLA mismatching in unrelated hematopoietic cell transplantation.
|
pubmed:affiliation |
Division of Clinical Research, D4-100 Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA. epetersd@fhcrc.org
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|